Laurus Labs Share price target & analyst calls
₹2,424+24.00 (+1.00%)
As of 13 Nov 2026
Avg 1-year target
Analysts split · 10 long-term calls₹2,283.335.8% below today's price
Laurus Labs' average 1-year share price target is ₹2,283.33, the average of 6 advisors' latest targets. Targets range from ₹1,400 to ₹3,500.
Latest: Goldman Sachs ₹1,600 · 30 Oct 2026
11
6 BUY · 5 SELL, all horizons
6
with an active 1Y target
52%
64 of 123 closed calls hit
138
all horizons, open and closed
Watch LAURUSLABS for new buy/sell callsGet alertsSee 53 Pharmaceuticals & Biotechnology sector analyst picks
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
All tips · page 3 of 3
ABbyAkshay Bhagwat, JM FinancialStop-loss hit
1–2 Weeks* · 3 Jun 2026 · entry ₹1,392 · via ET Nowexit ₹1,354
ICbyIDBI CapitalExpired
1–2 Weeks* · 1 Oct 2026 · entry ₹1,991 · via IDBI Capital Research Calls Telegramexit ₹2,018.5
SSbyShivangi Sarda, Motilal OswalTarget hit
Intraday · 8 Sept 2026 · entry ₹1,870.8 · via CNBC Awaaz.exit ₹1,950
SBbySumeet Bagadia, Choice BrokingStop-loss hit
Intraday* · 13 Nov 2026 · entry ₹2,435 · via Zee Business (Live)exit ₹2,420
ABbyAshish Bahety, Profitmart SecuritiesStop-loss hit
Intraday* · 17 Aug 2026 · entry ₹1,821.8 · via CNBC Awaaz.exit ₹1,790
KBbyKunal BothraExpired
Intraday* · 23 Jun 2026 · entry ₹1,482.4 · via Zee Business (Live)exit ₹1,480.2
* Horizon not stated by the source; assumed from how far the target is from the entry price.
Compare Pharmaceuticals & Biotechnology targets
Most-covered stocks in the sector · average 1-year target
- SUNPHARMASun Pharmaceutical Industries Ltd.₹2,214+17.8% · 26 calls
- DRREDDYDr. Reddy's Laboratories Limited₹1,370-0.8% · 21 calls
- CIPLACipla Ltd.₹1,493+7.3% · 17 calls
- ZYDUSLIFEZydus Lifesciences Limited₹1,375+15.6% · 13 calls
- GLANDGland Pharma Limited₹3,554+6.6% · 11 calls
- LAURUSLABS· this stockLaurus Labs Ltd₹2,283-5.8% · 10 calls
Showing 101–138 of 138

